ໜ້າທຳອິດRHHBY • OTCMKTS
add
Roche Holdings AG Basel ADR Common Stock
$35,44
ຫຼັງປິດຕະຫຼາດ:(0,00%)0,00
$35,44
ປິດແລ້ວ: 22 ພ.ຈ., 16 ໂມງ 46 ນາທີ 30 ວິນາທີ GMT-5 · USD · OTCMKTS · ຂໍ້ຈຳກັດຄວາມຮັບຜິດຊອບ
ປິດກ່ອນໜ້າ
$35,29
ຂອບເຂດລາຄາໃນມື້
$35,39 - $35,64
ຂອບເຂດລາຄາໃນປີ
$29,20 - $42,43
ມູນຄ່າຮຸ້ນຕາມລາຄາຕະຫຼາດ
233,72 ຕື້ USD
ປະລິມານສະເລ່ຍ
1,15 ລ້ານ
ໃນຂ່າວ
ການເງິນ
ໃບລາຍງານຜົນໄດ້ຮັບ
ລາຍໄດ້
ລາຍໄດ້ສຸດທິ
(CHF) | ມິ.ຖ. 2024info | ການປ່ຽນແປງ ປ/ປ |
---|---|---|
ລາຍໄດ້ | 15,38 ຕື້ | 0,46% |
ຄ່າໃຊ້ຈ່າຍການດຳເນີນການ | 6,22 ຕື້ | 0,75% |
ລາຍໄດ້ສຸດທິ | 3,13 ຕື້ | -12,32% |
ສ່ວນແບ່ງກຳໄລສຸດທິ | 20,35 | -12,70% |
ລາຍໄດ້ຕໍ່ຮຸ້ນ | — | — |
EBITDA | 6,17 ຕື້ | 1,01% |
ອັດຕາອາກອນທີ່ມີຜົນ | 18,56% | — |
ໃບດຸ່ນດ່ຽງ
ຊັບສິນທັງໝົດ
ໜີ້ສິນທັງໝົດ
(CHF) | ມິ.ຖ. 2024info | ການປ່ຽນແປງ ປ/ປ |
---|---|---|
ເງິນສົດ ແລະ ລົງທຶນໄລຍະສັ້ນ | 8,81 ຕື້ | 17,38% |
ຊັບສິນທັງໝົດ | 95,79 ຕື້ | 13,53% |
ໜີ້ສິນທັງໝົດ | 62,91 ຕື້ | 16,44% |
ຫຸ້ນທຶນທັງໝົດ | 32,88 ຕື້ | — |
ຮຸ້ນທີ່ຄ້າງຈ່າຍ | 796,79 ລ້ານ | — |
ລາຄາຕໍ່ມູນຄ່າທາງບັນຊີ | 0,97 | — |
ລາຍຮັບຈາກຊັບສິນ | 14,16% | — |
ລາຍຮັບຈາກທຶນ | 19,64% | — |
ກະແສເງິນສົດ
ການປ່ຽນແປງສຸດທິເປັນເງິນສົດ
(CHF) | ມິ.ຖ. 2024info | ການປ່ຽນແປງ ປ/ປ |
---|---|---|
ລາຍໄດ້ສຸດທິ | 3,13 ຕື້ | -12,32% |
ເງິນສົດຈາກການດໍາເນີນງານ | 3,96 ຕື້ | 0,20% |
ເງິນສົດຈາກການລົງທຶນ | -1,43 ຕື້ | -494,40% |
ເງິນສົດຈາກການເງິນ | -2,72 ຕື້ | 34,29% |
ການປ່ຽນແປງສຸດທິເປັນເງິນສົດ | -276,00 ລ້ານ | 56,57% |
ການເງິນສະພາບຄ່ອງ | 3,19 ຕື້ | -2,82% |
ກ່ຽວກັບ
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021. Roche is one of the few companies increasing their dividend every year, for 2020 as the 34th consecutive year.
F. Wikipedia
ສ້າງຕັ້ງ
1 ຕ.ລ. 1896
ສໍານັກງານໃຫຍ່
ເວັບໄຊ
ພະນັກງານ
103.605